Trial intelligence / Profile preview

ARMYDA RELOAD ACS: Clopidogrel Reloading in NSTE-ACS

NCT01572129Phase 4Unknown

Sponsor
Università Campus Bio-Medico di Roma
Start
Nov 2011
Primary completion
May 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of clopidogrel in acute coronary syndrome (ACS), sponsored by Università Campus Bio-Medico di Roma. Status: unknown.

02

Drugs

clopidogrel
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT01572129.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01572129.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call